RefleXion Medical is a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer.
Reflexion medical is using each cancer’s unique biology as a means to reveal its location and then destroy it.
Reflexion medical was founded in 2009 by Sam Mazin and Akshay Nanduri. The company is headquartered in Hayward, California.
RefleXion Medical's technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.
RefleXion’s patented technology* causes tumors to continuously signal their location during radiotherapy delivery, potentially transforming radiotherapy from an early stage, local therapy into one suitable for metastatic disease.
RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.
RefleXion Medical is backed by Oxford Finance, PSP Investments, TPG’s The Rise Fund, KCK Group, Sofinnova Partners and others. The company raised $100M in equity financing on Apr 16, 2020. This brings RefleXion's total funding to $323.6M to date.